A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production base of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, April 11, 2020. (Xinhua/Zhang Yuwei) According to Peru's National Institute of Health, which is overseeing the process, 11,000 volunteers have been vaccinated since the trials began in September. LIMA, Jan. 6 (Xinhua) Peru has signed an agreement with Chinese.
Last Updated:
Peru Suspends China Vaccine Trials Due To serious Adverse Event
Peru has halted the clinical trials for China’s Sinopharm COVID-19 vaccine candidate reportedly due to “serious adverse event” involving one of the volunteers.
Peru has halted the clinical trials for China’s Sinopharm COVID-19 vaccine candidate reportedly due to a “serious adverse event” involving one of the volunteers for the study. The Peruvian government reportedly said in a statement that the event is currently “under investigation to determine if it is related to the vaccine or if there is another explanation.”
China’s Sinopharm Group Co Ltd is conducting trials in Peru with nearly 12,000 volunteers and neurological problems in one of its participants just when it was about to complete the first stage of trials in the next few days. Meanwhile, as Peru has recorded more than 36,000 deaths due to COVID-19, the country’s health ministry said in a statement that the decisio